Condition
Steroid Resistant Nephrotic Syndrome
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Terminated1
Completed1
Unknown1
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06065852Recruiting
National Registry of Rare Kidney Diseases
NCT01113385Not ApplicableCompleted
Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome
NCT00883636Terminated
Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis
NCT01716442Phase 2UnknownPrimary
Rituximab Trial for Pediatric Nephrotic Syndrome
Showing all 4 trials